Bioiberica español  |  english
   inicio px articular px digestiva barra vegetal barra heparina
menu
estás en: Bioiberica  >  Salud Articular  >  División Joint Care  >  e-Newsletter

Eboletin Joint Care

- ESTE CONTENIDO SÓLO ESTÁ DISPONIBLE EN INGLÉS -

ARCHIVO
Nombre               Contenido Ver
[#8 / Mar 2008 ]
  • Bioiberica is the first company to obtain the certificate of suitability for chondroitin sulphate
  • New findings on hyal-joint efficacy presented at OARSI
  • Bioiberica at the world congress on osteoarthritis (OARSI)
  • Heparin science: new bioiberica business unit
  • Bioiberica veterinary consolidates its international position
[#7 / Nov 2007 ]
  • Bioibérica Presents Symposium on Synovitis at EULAR Congress
  • Dr Theodosakis at Bioiberica's booth at Supplyside exhibition
  • Hyal-Joint Website
  • Attendance at CPhI Trade Fair
  • Attendance at SupplySide West Trade Fair
[#6 / Mar 2007 ]
  • Overview of 2006
  • CS Bio-Active Website
  • New Heparin Plant
  • Bioiberica launches new corporate website
  • New staff member
  • Hyal-Joint Clinical Trial at the ACN Congress
[#5 / Jul 2006 ]
  • Bioiberica targets American specialist doctors
  • The Nutraceuticals Market in Europe and Joint Health Products
  • Customer-Satisfaction Survey
  • New Plant in South America
  • Poster Presentation at EULAR 2006
[#4 / NIH GAIT]
  • NIH GAIT Study - Encouraging data on the efficacy of the combination Chondroitin and Glucosamine
  • NIH GAIT Study - Chondroitin effective in Joint Swelling and K-L Grade 2 OA
  • Publication of the NIH Study
  • Chondroitin Symposium
  • 4 new studies in the OARSI Congress
[#3 / Aug 2005]
  • CS Bio-Active: The Chondroitin tested in the NIH Trial
  • Bioiberica Symposium at the ACR Meeting
  • Bioiberica presents its recent scientific findings during the Spanish Rheumatology Society (SER) conference
  • New members of staff
  • Glucosamine licence granted to Almirall
  • CPHI 2005
  • Supplyside West 2005
[#2 / Apr 2005]
  • In 2004 Bioiberica consolidated its leadership in joint health
  • A positioning study reflects market perceptions of Bioiberica
  • 1 out of every 4 Spanish patients treated with chondroprotectors uses a product from Bioiberica
  • VITAFOODS 2005
  • BIOIBERICA AT THE AAOS CONGRESS
[#1 / Dec 2004]
  • The start-up of Joint Care e-Newsletter
  • New Marketing Approach of Bioiberica Joint Care
  • New Technical Office
  • New Manufacturing Plant
  • Bioiberica at CPhI
jointcare
» QUIÉNES SOMOS
» PRODUCTOS
  » BIO-ACTIVE
  » Chondroitin Sulfate
» Glucosamine
» Sodium Hyaluronate
» NUTRI-JOINT
  » Hyal-JointTM
» Palbio 20
» Hydrolysed Collagen
» Native Collagen
» FINISHED PRODUCTS
» NOTICIAS
» PUBLICACIONES
  » GAGS NEWS
» JOINT CARE EXPRESS
» e-NEWSLETTER
  » ARCHIVO
» SUSCRIBIRSE
» CONTACTAR
pharma
sport
vet






px
Inicio - Aviso Legal - Política de protección de datos - Contactar - Site Map
Compañía - Salud Articular - Salud Digestiva - Salud Vegetal - Linea Heparina
Joint Care - Farma - Sport Nutrition - Veterinaria
BIOIBERICA, S.A.
Plaza Francesc Macià , 7
Barcelona 08029 (SPAIN)
Tel.: +34 93 490 49 08